• 

  February 12, 2026

  Wyss Institute-Led Team Wins ARPA-H PRINT Award to Engineer Universal, Transplant-Ready Liver Grafts known as ImPLANT

  R.D. Solorzano

• 

  February 9, 2026

  Carnegie Mellon Team Wins $28.5M ARPA-H Award to Bioprint Regenerative Human Livers

  R.D. Solorzano

• 

  February 5, 2026

  ARPA-H’s $176M Bet on Bioprinted Organs: Inside the PRINT Program’s Push to End Transplant Shortages

  R.D. Solorzano

• 

  January 3, 2026

  The Business of Biofabrication: What 2025 Taught Us

  R.D. Solorzano

• 

  December 17, 2025

  restor3d Completes First Clinical Cases of Fully Personalized 3D-Printed Knee Replacement System

  R.D. Solorzano

• 

  December 15, 2025

  Revalia Bio Secures ~$30M Government Contract to Build the Future of Human-First Drug Development

  R.D. Solorzano

• 

  December 11, 2025

  Inside Curi Bio’s Human Tissue Platforms: How They Work, What the $10M Series B Will Accelerate, and Why It Matters

  R.D. Solorzano

• 

  December 10, 2025

  Xeltis Secures Nearly €50M to Advance aXess Toward Market Entry as New Data Strengthen Clinical Profile

  R.D. Solorzano

• 

  November 28, 2025

  The Rise of the Tiger – Tiger BioSciences: Building a Fully Integrated Platform for Regenerative Medicine

  R.D. Solorzano

• 

  November 20, 2025

  InSphero Acquires Doppl SA, Expanding Its 3D Cell Culture Portfolio with the Gri3D® Platform

  R.D. Solorzano